Richard Adcock - 08 Oct 2021 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role: CEO & President, Director
Signature: /s/ Jason Liljestrom, as Attorney-in-Fact
Issuer symbol: IBRX
Transactions as of: 08 Oct 2021
Net transactions value: +$16,995
Form type: 4
Filing time: 08 Oct 2021, 20:31:00 UTC
Previous filing: 13 Sep 2021
Next filing: 08 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBRX	Common Stock	Purchase	$63	+7		$9.00	7	08 Oct 2021	See footnote	F1
transaction	IBRX	Common Stock	Purchase	$16,932	+1,923	+27471%	$8.80	1,930	08 Oct 2021	See footnote	F1
holding	IBRX	Common Stock						86,176	08 Oct 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by girlfriend living in the same household as the Reporting Person. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Content

Shares held by girlfriend living in the same household as the Reporting Person. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.